Rapid clinical deterioration and leukemoid reaction after treatment of urothelial carcinoma of the bladder: possible effect of granulocyte colony-stimulating factor.
Perez
Francisco A
FA
Department of Radiology, University of Washington School of Medicine, Seattle, WA, USA.
Fligner
Corinne L
CL
Yu
Evan Y
EY
D002295:Carcinoma, Transitional Cell / Q000097:blood* / Q000556:secondary; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007955:Leukemoid Reaction / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000188:drug therapy; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D001749:Urinary Bladder Neoplasms / Q000097:blood* / Q000473:pathology
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; C455861:pegfilgrastim; D011092:Polyethylene Glycols; D000069585:Filgrastim